Transcriptomic analysis of benznidazole-resistant and susceptible Trypanosoma cruzi populations
Abstract Background Chagas disease (CD), caused by the parasite Trypanosoma cruzi, is a serious public health concern in Latin America. Nifurtimox and benznidazole (BZ), the only two drugs currently approved for the treatment of CD, have very low efficacies in the chronic phase of the disease and se...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-05-01
|
Series: | Parasites & Vectors |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13071-023-05775-4 |